Episode Details
Back to EpisodesAlcon Gains FDA Approval for Novel DED Drug
Published 11 months, 4 weeks ago
Description
Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials.
Learn more about your ad choices. Visit megaphone.fm/adchoices